News Daily News REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19 Todd Neale March 22, 2022
News Daily News No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX Shelley Wood October 03, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Daily News Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion Shelley Wood April 18, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
News Daily News Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128 Caitlin E. Cox December 20, 2015
News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Conference News ESC 2015 NSAIDs Plus Anticoagulants a Bad Combination Caitlin E. Cox September 01, 2015
News Daily News Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence Leah Lawrence August 30, 2015
News Industry News NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults July 13, 2015
News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015